IMM 4.24% 30.8¢ immutep limited

Ahjay - in the absence of actual ‘new news’ in the form of hard...

  1. 39 Posts.
    lightbulb Created with Sketch. 4
    Ahjay - in the absence of actual ‘new news’ in the form of hard data or emerging fresh partnerships, I can’t help thinking that most of the price move north lately might just be on the coat tails of the biotech industry generally, which has - I think to a large degree - been caught up in the Covid cure speculation that’s rife across the market. There doesn’t appear to be any end in sight to the Fed’s green printing press. I reckon a lot of that hot money has been - and will continue to be - poured into (among other things) spec on biotechs.
    SP hikes might be wishful thinking around impending LAG525 results ...or excitement about the boost from 200 to 2000 litres of efti - or neither. Your thoughts?
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.